The largest database of trusted experimental protocols

30 protocols using cw0102

1

Western Blot Quantification of Metabolic Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein concentrations of extracts were analyzed by western blot using commercially available antibodies purchased from Bioworld Technology, Inc., for PPARγ (MB0080) and FAS (MB22759); from Santa Cruz Biotechnology, Inc., for HSL (sc-25843); and from Beijing Biosynthesis Biotechnology Co., LED for GAPDH (bsm-0978M). The secondary antibodies were provided by CWBIOTECH for PPARγ (CW0102), FAS (CW0105), HSL (CW0103), and GAPDH (CW0102).
+ Open protocol
+ Expand
2

Chondrogenic Differentiation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
A semiquantitative analysis of differentiation was performed on cell-seeded hydrogels via Western blotting as described previously using the following antibodies that were diluted in 3% BSA in TBST buffer: aggrecan (1 : 1000, sc-16492, Santa Cruz Biotechnology, USA), Col II (1 : 5000, ab34712, Abcam, USA), and Sox-9 (1 : 1000, sc-20095, Santa Cruz Biotechnology, USA) antibodies and goat anti-mouse horseradish peroxidase-conjugated secondary antibody (1 : 2000, CW0102, Cwbiotech). And the protein level was quantified and normalized to GAPDH bands by densitometry in Quantity One software (version 4.6.2, Bio-Rad, n = 3).
+ Open protocol
+ Expand
3

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (washed three times with PBS) and the tissues were lysed in a RIPA lysis buffer (CW2333, CWBIO, China) with protease inhibitor (CW2200, CWBIO, China) and phosphatase inhibitor cocktail (CW2383, CWBIO, China) for 45 min. Protein concentrations of cell lysates and tissue lysates were determined using a Pierce BCA Protein Assay Kit (CW0014, CWBIO, China) according to the manufacturer's instructions. Total protein (30-50 μg) for each sample was separated by the SDS–PAGE and transferred to polyvinylidene difluoride (PVDF, Millipore, IPVH00010) membranes. The membranes were blocked with 5% nonfat milk at room temperature for 2 h and then incubated with primary antibodies overnight at 4°C (for all antibodies, see Supplementary Table2). After washing, the membranes were incubated with a 1 : 8,000 dilution of goat anti-mouse or anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibodies (CW0102 and CW0103, CWBIO, China) at room temperature for 1.5 h. Protein bands were visualized using an Immobilon Western Chemiluminescent HRP Substrate (WBKLS0500, Millipore) via an automatic chemiluminescence imaging analysis system (Tanon-5200, USA). ImageJ (NIH, National Institutes of Health, USA) was used to analyse these images.
+ Open protocol
+ Expand
4

Western Blot Analysis of Recombinant Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial cultures were grown at 37 °C in DMEM to an OD600 of ≈1.0. The whole cells were harvested by centrifugation at 12,000g for 5 min, washed with PBS (pH 7.4), centrifuged, resuspended in ≈100 μl SDS–polyacrylamide gel electrophoresis solubilization buffer (normalized for OD600) and lysed at 100 °C for 10 min. Proteins were separated via 10% SDS–polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. The membranes were blocked with TBST (Tris-buffered saline with Tween 20) containing 5% non-fat milk for 1 h at room temperature. Incubations with the primary antibody anti-His (1:2,500 dilution, CWBIO; # CW0286) or anti-FLAG (1:2,500 dilution, Sigma; # F1804) and the secondary antibody goat anti-mouse-HRP (1:5,000 dilution, CWBIO; # CW0102) were then carried out for 1 h at room temperature. Blots were washed in TBST followed by detection with the ECL enhanced chemiluminescence reagent.
+ Open protocol
+ Expand
5

Visualizing ECM Deposition via Aggrecan Immunostaining

Check if the same lab product or an alternative is used in the 5 most similar protocols
For visualizing analysis of ECM deposition, collected hybrids were moved into paraffin and sectioned in 4 μm thickness (n = 3). Thereafter, the sections were immunostained with aggrecan following a standard immunohistochemistry staining procedure. The aggrecan (1 : 400, sc-16492, Santa Cruz Biotechnology, USA) and goat anti-mouse horseradish peroxidase-conjugated secondary antibody (1 : 1000, CW0102, Cwbiotech, USA) were applied in the analysis.
+ Open protocol
+ Expand
6

Quantification of Target Proteins by Immunoblotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
The levels of the target proteins were measured with the following primary antibodies: anti-CNPase (1:1,000, ab6319, Abcam), anti-myelin basic protein (MBP; 1:1,000, ab62631, Abcam), anti-neuron glia 2 (NG2; 1:1,000, sc-33666, SANTA CRUZ), anti-GSK3β (1:1,000, D5C5Z, CST), anti-phosphorylated (Ser9) GSK3β (p-ser9-GSK3β; 1:1,000, D85E12, CST), anti-5-HT1AR (1:1,000, ab85615, Abcam), anti-human gene and protein symbol ACTB/ACTB (β-actin; 1:5,000, ab8226, Abcam), and anti-heat-shock protein 90 (HSP90; 1:2,000, ab203126, Abcam). The corresponding secondary antibodies (goat anti-rabbit IgG, CW0103 and goat anti-rabbit IgG, CW0102, CWBIO, P. R. China) for each protein were applied at a dilution of 1:1,000, followed by development with an ECL kit (AR1111, Boster, P. R. China). The band intensity was quantified using Image Lab software (version 5.2.1).
+ Open protocol
+ Expand
7

Protein Expression Analysis in Cell Lysates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total proteins were extracted from cells using RIPA lysis buffer (Invitrogen, Carlsbad, CA, USA). After determining protein concentration, 20 μg of total protein from each sample was separated with 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis and then transferred to polyvinylidene fluoride membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% nonfat milk and incubated with anti-human c-Myc (dilution, 1 : 300; 10057-1-AP, Proteintech, Chicago, IL, USA), Bcl-2 (dilution, 1 : 200; 2870, Cell Signaling Technology, USA), Bax (dilution, 1 : 200; BS2538, Bioworld, USA), cyclin-D1 (dilution, 1 : 500; BS1741, Bioworld, USA), and Glut1 (dilution, 1 : 1000; FO6231163, Wanleibio, Shenyang, China) antibodies overnight at 4°C and then incubated with goat anti-mouse (dilution, 1 : 2000; CW0102, CWBIO, Beijing, China) and goat anti-rabbit (dilution, 1 : 2000; CW0103, CWBIO, Beijing, China) secondary antibodies for 1 hour at 37°C. The blots were visualized using the enhanced chemiluminescent detection system (Amersham, Amersham, UK) and analyzed using Image-Pro Plus version 5.1 (Media Cybernetics Inc., Rockville, MD, USA).
+ Open protocol
+ Expand
8

Protein Extraction and Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
To extract total protein from GMEC, cells were washed and lysed with RIPA buffer (R0010, Solarbio Tech Inc., Beijing, China) supplemented with protease inhibitor cocktail tablets (04693132001, Roche., Mannheim, Germany). Detailed procedures of Western blotting are reported in one of our previous studies [32 (link)]. The primary antibodies used were rabbit anti-β-casein (bs-0466R, Bioss, Woburn, CA; 1:1000), rabbit anti-INSIG1 (bs-5074R, Bioss; 1:500), rabbit anti-FASN (10624-2-AP, Proteintech Group, Wuhan, China; 1:500), and mouse anti-β-tubulin (CW0098, CW Biotech, Beijing, China; 1:1000). Secondary antibodies included horseradish peroxidase (HRP)-conjugated goat anti-mouse_IgG (CW0102, CW Biotech; 1:4000) and HRP-conjugated goat anti-rabbit_IgG (CW0103, CW Biotech; 1:4000). Protein abundance was measured using the ImageJ software. The relative abundance of FASN and INSIG1 proteins was calculated by normalizing to β-Tubulin.
+ Open protocol
+ Expand
9

Recombinant FtGH1 Protein Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full‐length cDNA of FtGH1 was amplified and constructed into the pD2P_1.08e‐8His expression vector. Positive cloned DNA templates were added directly to ProteinFactory RXN to a final template concentration of 20 ng/μL. Protein production was accomplished by the reaction of 5 mL of ProteinFactory RXN reaction solution in a 12‐well plate container at 28 °C on a 150 rpm shaker for 6 h. The ProteinFactory RXN reaction solution was then centrifuged at 1986 g for 3 min at 4 °C and the supernatant was collected. His‐Monster Beads were used to purify recombinant proteins. Immunoblotting of FtGH1‐His was performed with anti‐His (1 : 3000; CW0082A, CWBIO, Taizhou, Jiangsu, China) and anti‐mouse IgG (1 : 8000; CW0102, CWBIO) antibodies.
For FtGH1 activity assay, 0.1 μg purified protein was added to the reaction buffer (20 mm ammonium acetate buffer, pH 5.0, 0.5 mm rutin (SR8250; Solarbio, Beijing, China), 1 mm ATP) and incubated at 37 °C for 30 min. After terminated by freeze dryer at −40 °C, the dried reaction products were re‐dissolved in 80% methanol for analysed by HPLC–MS (Nexera XR UHPLC/HPLC System).
+ Open protocol
+ Expand
10

Histological Analysis of Cell-ECM Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
For histological analysis of cell morphology and ECM secretion, hybrids from each time point (7, 14, and 28 days) were moved into paraffin. Then in order to visualize the ECM deposition of the hybrids, the sections were immunostained by collagen II and aggrecan as in reported method [30 (link)]. The aggrecan (1 : 400, sc-16492, Santa Cruz Biotechnology, USA), type II collagen (1 : 400, ab34712, Abcam, UK), and goat anti-mouse horseradish peroxidase-conjugated secondary antibody (1 : 1000, CW0102, Cwbiotech, USA) were applied in the analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!